BackGwo Xi Stem Cell Applied Technology , Ltd Overview

Gwo Xi Stem Cell Applied Technology , Ltd Total Liabilities

Gwo Xi Stem Cell Applied Technology , Ltd's total liabilities is $370M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$370.73M
↓ 4.27% YoYΔ $-16.53M vs prior year quarter

Peer trimmed avg / median

Loading

Gwo Xi Stem Cell Applied Technology , Ltd Total Liabilities History

Loading

Gwo Xi Stem Cell Applied Technology , Ltd vs. peers: Total Liabilities Comparison

Loading

Gwo Xi Stem Cell Applied Technology , Ltd Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Gwo Xi Stem Cell Applied Technology , Ltd (6704.TWO) FAQ

Gwo Xi Stem Cell Applied Technology , Ltd's total liabilities stands at $370M as of June 2026. That compares with $390M in the prior-year period — down 4.3% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Gwo Xi Stem Cell Applied Technology , Ltd reported $370M in total liabilities versus $390M a year earlier — a 4.3% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $390M in the prior-year period — down 4.3% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Gwo Xi Stem Cell Applied Technology , Ltd's total liabilities evolved across reporting periods, while the comparison chart places 6704.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total liabilities is commonly used to spot outliers. Gwo Xi Stem Cell Applied Technology , Ltd's reading of $370M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.